Evidence map›Paper›PMID 42690854›Full record

ArticleThe Indian journal of medical research2026

Burden of sickle cell disease among pregnant women in central India.

Sayali C Tiwari, Nagaraj Jaganathasamy, Chhedi Lal Gupta, Aruna Anil Jawade, Nagamuralidhar Merugu, Pallavi Thaker, Nikhil Shinde, Sneha Dadheech, Vinod Umare, Projyot Vijayrao Deshmukh and 3 more

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Sayali C TiwariDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Nagaraj JaganathasamyDepartment of Biostatistics, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Chhedi Lal GuptaDepartment of Bioinformatics, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Aruna Anil JawadeICMR-National Institute for One Health, Nagpur, Maharashtra, India.
Nagamuralidhar MeruguDepartment of Molecular Biology, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Pallavi ThakerDepartment of Haematogenetics, National Institute for Research on Blood and Immune Disorders, Mumbai, Maharashtra, India.
Nikhil ShindeDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Sneha DadheechDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Vinod UmareDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Projyot Vijayrao DeshmukhDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Prabhakar KedarDepartment of Haematogenetics, National Institute for Research on Blood and Immune Disorders, Mumbai, Maharashtra, India.
Malay B MukherjeeDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.
Manisha MadkaikarDepartment of Clinical Medicine & Public Health, ICMR-Centre for Research Management and Control of Haemoglobinopathies, Chandrapur, Maharashtra, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sickle cell disease (SCD) is a major public health concern in central India. This study aims to estimate the prevalence of haemoglobinopathies, haematological variations, family screening status, prenatal diagnosis and pregnancy outcomes among pregnant women. A total of 11,602 pregnant women were screened between 2017 and 2022. Among the screened, the prevalence of sickle cell homozygous (SS) and sickle β-thalassemia (Sβ-thal.) was 0.25% and 0.38%, respectively. The haematological parameters differed significantly (P < 0.05) between the phenotypic groups. In a retrospective analysis, we found that only 61.1% (n=204) of spouses and 42.5% (n=226) of children were screened for SCD. Pregnant women with SCD had longer hospital stays, a lower birth weight, a higher incidence of preterm birth, an increased likelihood of caesarean delivery, and a higher rate of blood transfusions. Our study highlights the importance of early screening for pregnant women for SCD.

Indexed as

Anemia, Sickle Cellbeta-ThalassemiaPregnancy Complications, HematologicAdultBlood TransfusionFemaleHumansIndiaPregnancyPregnancy OutcomePremature BirthPrenatal DiagnosisPrevalenceRetrospective StudiesHaemoglobinopathiesPregnant womenPrevalenceScreeningSickle cell disease

Identifiers

PMID42690854
PMCPMC13541125

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.